抗组织因子抗体能够抑制HT10 80向血管内游走。
The antibody for tissue factor inhibited intravascular migration of tumor cells.
组织因子（TF）是生理性凝血过程中最重要的启动因子。
Tissue factor(TF)is the most important factor in the physiological coagulation process.
目的探讨组织因子表达对结直肠癌细胞血行转移能力的影响。
Objective To investigate the role of tissue factor(TF) in hematogenous metastasis of human colorectal carcinoma cells (LOVO) in vivo.
这些炎症刺激可使组织因子的形成增多，尤其是在单核细胞内。
These types of inflammatory stimuli give rise to the formation of the tissue factor, primarily on monocytes .
目的研究组织因子(TF)在肾癌中的表达并探讨其临床意义。
Objective to study the expression of tissue factor (TF) in renal cell carcinoma and investigate its clinical significance.
组织因子通路抑制物是内源性组织因子抑制物，对调剂血栓形成有重要作用。
Tissue factor pathway inhibitor (TFPI) is the endogenous inhibitor of TF and the role of TFPI is important for regulating the thrombus formation.
组织因子途径抑制物- 2；急性髓系白血病；血管内皮生长因子；白血病。
Tissue factor pathway inhibitor-2; Acute myelocytic leukemia; VEGF; leukemia.
目的探讨大鼠脑皮质微血管血栓模型中组织因子(TF)表达的动态变化及意义。
AIM: to study the expression of tissue factor (TF) in cerebral microvascular thrombosis and its dynamic changes in rats.
结果发现：外源性的组织因子途径抑制物(TFPI)可使PT及APTT延长。
The results showed that PT and APTT were prolonged by exogenous TFPI.
最近的研究显示，皮肤涂抹喜疗妥后还能激活组织因子旁路抑制因子(TFPI)。
In recent studies an activation of the tissue factor pathway inhibitor (TFPI) could be shown after cutaneous application of MPS.
目的 ：研究三七总甙对NB4细胞促凝活性和组织因子表达及诱导分化作用的影响。
Objective:To investigate the effect of Panax notoginseng saponin (PNS) on procoagulant activity (PCA) and differentiation induction in NB4 cells.
组织因子途径抑制物-2 (TFPI - 2)是凝血途径的重要生理拮抗剂之一。
Tissue factor pathway inhibitor 2 (TFPI-2) is one of the most important physiological antagonist in blood clotting.
组织因子在凝血生理中扮演重要角色，同时也参与炎症促发过程和粥样硬化斑块失稳定。
TF plays a pivotal role in blood clotting physiology and is involved in pro-inflammatory action and atherosclerotic plaque destabilization.
采用RNA干扰降低膜联蛋白A2表达后单核细胞株THP-1的组织因子表达显著降低。
The TF expression was dramatically decreased in THP-1 cells with less Annexin A2 expression as a result of RNA interference.
近年研究发现，组织因子(TF)是凝血瀑布的主要启动因素，在动脉血栓形成中起关键作用。
Recent studies have showed tissue factor (TF) plays a major role in arterial thrombosis. TF is the main initiator of the coagulation cascade.
目的：研究血浆组织因子途径抑制物（TF PI） 抗原含量及活性对卵巢癌患者的临床意义。
Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer.
与安慰剂组不同的是，多磺酸粘多糖乳膏组，总的和游离的组织因子旁路抑制因子水平持续增加。
In contrast to the placebo group a progressive increase of total and free TFPI was determined after the administration of the MPS cream.
目的：研究组织因子（TF）反义寡脱氧核苷酸（AS/TF）对大鼠心肌缺血再灌注损伤的作用。
Objective To study the effects of antisense oligodeoxynucleotide(AS/TF) for rat tissue factor (TF) on the myocardial ischemic reperfusion injury.
目的：探讨兔髂动脉球囊剥脱术后局部灌注重组组织因子途径抑制物蛋白对血管内膜增生的抑制作用。
AIM to investigate the inhibitory effect of local perfusion of recombinant tissue factor pathway inhibitor protein on intima hyperplasia in atherosclerotic arteries after balloon stripping in rabbits.
方法：应用流式细胞仪和免疫荧光染色法检测组织因子在纤维肉瘤细胞（HT10 80 ）的表达情况；
METHODS: Expression of tissue factor in tumor cells (HT1080) was analyzed by flow cytometry and immunofluorescence staining.
研究发现组织因子(TF)位于血管外膜和粥样斑块的脂质中心，并特异地表达于单核细胞和巨噬细胞膜表面。
Tissue factor (TF) is found in the adventitia of blood vessels and in the lipid core of atherosclerotic plaques, and is specifically expressed on monocyte or macrophage cell membrane surfaces.
目的探讨高盐饮食对自发性高血压卒中倾向鼠(SHRSP)血浆组织因子途径抑制物(TFPI)活性的影响。
Objective to investigate whether tissue factor pathway inhibitor (TFPI) activity is influenced by high sodium loading in spontaneously hypertension stroke-prone (SHRSP) rats.
当血管壁受损，胶原蛋白和组织因子暴露，循环血小板通过血管性血友病因子的作用发生黏着，并伴形状改变和ADP的释放。
When vessel walls are damaged, collagen and tissue factor are exposed, and circulating platelets adhere via von Willebrand factor and undergo a change in shape with the accompanying release of ADP.
目的探讨单核源巨噬细胞分泌的基质金属蛋白酶- 9 (MMP - 9)、组织因子(TF)在冠心病中的临床意义。
Objective to investigate the clinical significance of matrix metalloproteinase-9 (MMP-9) and tissue factor (TF) secreted by monocyte derived-macrophages in vitro in coronary heart disease (CHD).
目的探讨角膜基质细胞组织因子途径抑制物2 (TFPI - 2)的表达情况，为角膜新生血管的基因治疗提供方法。
Objective to observe the expression of TFPI-2 in corneal keratocytes in vitro and investigate the experimental basis for curing corneal neovascularization with gene-therapy.
目的观察原发性高血压患者血浆组织因子途径、组织因子途径抑制物的变化及用依那普利、特拉唑嗪降压治疗后上述指标的变化。
Objective to observe the changes of tissue factor pathway (TFP) and tissue factor pathway inhibitor (TFPI) in essential hypertension and study the effects of enalapril and terazosin.
结论：组织因子途径抑制物作为组织因子途径凝血过程的抑制物，间接反应了不稳定心绞痛发作过程中血管内皮的损伤和凝血状态。
CONCLUSION: TFPI acted as an inhibitor of tissue factor pathway reflected the vascular endothelial injury and the states of coagulation indirectly in unstable angina progression.
结论：组织因子途径抑制物作为组织因子途径凝血过程的抑制物，间接反应了不稳定心绞痛发作过程中血管内皮的损伤和凝血状态。
CONCLUSION: TFPI acted as an inhibitor of tissue factor pathway reflected the vascular endothelial injury and the states of coagulation indirectly in unstable angina progression.
应用推荐